Search results
Found 1355 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Hidden damage to lungs from COVID-19 revealed in new research study from University of Oxford & Sheffield
Coronavirus COVID-19 General Research
2 December 2020
Early findings from a study into longer-term damage amongst patients recovering from COVID-19 suggest that the use of cutting-edge scanning techniques may detect previously unseen lung damage.
SCALOP team discover new pancreatic cancer biomarker
General Research
30 November 2020
The discovery of pancreatic cancer biomarkers (naturally occurring molecules, genes or characteristics which can be used to confirm the presence or predict the outcome of a cancer) is vital in understanding patient outcomes and finding new therapeutic targets.
A clue to how a memory-enhancing pill might work
General Research
27 November 2020
Hundreds of dietary supplements have been reported to improve cognitive and emotional function in humans, but few have scientific foundation. A new study from the Department of Physiology, Anatomy & Genetics (DPAG) provides fresh insight into how dietary magnesium supplementation can influence memory performance.
Inhaled corticosteroids to be investigated as a possible treatment for Covid-19 in national PRINCIPLE Trial
Coronavirus COVID-19 General Research
27 November 2020
In Covid-19, inhaled budesonide may prevent damaging inflammation, stop the virus from getting into lung cells and inhibit viral replication.
New MRI technique could detect early signs of heart failure in cancer patients following chemotherapy
General Research
25 November 2020
New research led by Department of Physiology, Anatomy & Genetics researcher Dr Kerstin Timm shows that a recently developed imaging technique can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.
Oxford University breakthrough on global COVID-19 vaccine
Coronavirus COVID-19 General Research
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
People in prison should be prioritised for any COVID-19 vaccine
Coronavirus COVID-19 General Research
20 November 2020
Preventing serious complications from COVID-19 in potentially vulnerable populations in high risk environments, such as prisons, and preventing spread to surrounding communities needs a coordinated evidence-based approach to managing outbreaks of COVID-19 in prison settings.
Prior COVID-19 infection offers protection from re-infection for at least six months
Coronavirus COVID-19 General Research
20 November 2020
A new study suggests that individuals who have previously had COVID-19 are highly unlikely to contract the illness again, for at least six months following their first infection.
Transplant kidney survival rate improves with new method of transportation
General Research
20 November 2020
New research by the Consortium for Organ Preservation in Europe (COPE) has found that a new method to transport donor kidneys, which uses a combination of cold perfusion with oxygen, can significantly improve transplant results, with less graft failure, better function and lower rejection of the kidney when compared to cold perfusion alone. For patients who need a kidney transplant this is a big step forward. The study, carried out in Belgium, The Netherlands and the UK, was published today in The Lancet.
Viruses shown to evolve as a result of different immune responses in different ethnic populations
Coronavirus COVID-19 General Research
20 November 2020
New research into the HIV-1 virus has shed light on an important factor in the evolution of viruses, which is likely also to affect SARS-CoV-2 (the virus which causes COVID-19). This new insight could have important implications for vaccine development.
Oxford coronavirus vaccine produces strong immune response in older adults
Clinical Trials Coronavirus COVID-19 General Research
19 November 2020
The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.
Top numbers of Oxford researchers make Highly Cited Researchers list
General
18 November 2020
Oxford University is delighted that 52 of its academics have been named on the annual Highly Cited Researchers™ 2020 list from Clarivate. This number is the highest number in the UK and 2nd highest in Europe.
Evox Therapeutics announces launch of strategic collaboration with the University of Oxford
General Innovation
18 November 2020
Collaboration with world-renowned research centre to accelerate development of exosome therapies for rare diseases
Africa’s 35 Under 35 Award
Awards and Appointments General Staff and student stories
18 November 2020
Toluwalase Awoyemi, DPhil student in Nuffield Department of Women's & Reproductive Health, is recognised with an Africa 35.35 Award - a celebration of the top 35 leading young changemakers under 35 in Africa in 2020.
University of Oxford welcomes Dr Ira Milosevic as John Black Senior Research Fellow in Parkinsons's Disease research
General
18 November 2020
The University of Oxford, in association with the John Black Charitable Foundation, is pleased to welcome Dr Ira Milosevic as a John Black Senior Research Fellow in Parkinson’s Disease Research.
Young Scientist Award
Awards and Appointments General
17 November 2020
Magda Marečková, Nuffield Department of Women's & Reproductive Health DPhil student, has won this year's special prize, the Special Young Scientist Award at the Fast Forward Science 2020 web-video competition. She wins for her compelling video: "Heavy periods, sharp pain and no one to listen to you? Could you have Endometriosis?".
Return to school sees improvement in children's mental health
Coronavirus COVID-19 General Research
17 November 2020
Mental health difficulties in children increased during the first national lockdown (between March and June 2020), but have decreased since.
Interferon-b trial shows positive results
Clinical Trials Coronavirus COVID-19 General Research
16 November 2020
A trial of a new inhaled antiviral drug for COVID-19 has shown positive results and the drug is now moving into a larger international phase 3 trial of hospitalised patients.